Published in Cancer Weekly, February 19th, 1996
The protein was discovered by a group of scientists headed by Dr. Ruth Sager of the Dana-Farber Cancer Institute, Boston, Massachusetts. The team of researchers at Dana-Farber, in collaboration with scientists from LXR Biotechnology, reported that Maspin levels in highly metastatic breast tumors are greatly reduced.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.